COMMUNIQUÉS West-GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - February 2024
15/03/2024
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - FEVRIER 2024
15/03/2024
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.
15/03/2024
The certification has the potential to open access to Islamic markets globally, expanding potential markets for Scilex’s innovative FDA approved non-opioid therapies and pipeline candidate products. The certification is [...]
Gain Therapeutics to Present at Public Ventures Discovery Day
15/03/2024
Gain Therapeutics’ Former CEO and current Board Member Eric Richman to participate in fireside chat hosted by Public Ventures President Lou Basenese and Aberdeen Investment Management President Jeb Terry, Sr. BETHESDA, [...]
Ibogaine By David Dardashti: Government Urged to Increase Funding for Quantum Electrodynamics Research
15/03/2024
Exploring the Relationship Between Glial Cells and Electromagnetic Waves MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti today announced that they are advocating to the government to increase [...]
Quantum Electrodynamics and Chaos Theory Enhance Ibogaine's Psychological Experience
15/03/2024
Ibogaine By David Dardashti applies the principles of Quantum Electrodynamics and Chaos Theory to optimize the ibogaine experience MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is introducing a [...]
Healthcare Triangle, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
15/03/2024
PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a leader in digital transformation solutions including managed services, [...]
SELLAS Life Sciences Group Announces $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
15/03/2024
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for [...]
Oncternal Participating in Virtual Fireside Chat with Key Opinion Leader on Treatment Landscape & New Treatment Options for Prostate Cancer
15/03/2024
SAN DIEGO, March 15, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced it will [...]
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity
15/03/2024
Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, March 20th at 12:00 PM ET OCALA, Fla., March 15, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or [...]
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
15/03/2024
Company to host conference call to discuss financial results and provide a corporate update on March 21, 2024 at 4:30 p.m. ET SCOTTSDALE, Ariz., March 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey [...]
Sienna Announces March Dividend
15/03/2024
MARKHAM, Ontario, March 15, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Eupraxia Pharmaceuticals Announces Closing of Overnight Marketed Offering for Gross Proceeds of C$33.9 Million
15/03/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 15, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a [...]
Genmab Announces Initiation of Share Buy-Back Program
15/03/2024
Company Announcement Repurchase of up to DKK 3.5 billion worth of shares Completion expected no later than December 16, 2024 COPENHAGEN, Denmark; March 15, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that it is [...]
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
15/03/2024
MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the [...]
Nuvectis Pharma to Present at the 36th Annual Roth Conference
15/03/2024
FORT LEE, NJ, March 15, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious [...]
New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia
15/03/2024
Three additional patients with Fanconi Anemia treated with briquilimab prior to stem cell transplant All six patients with Fanconi Anemia treated with briquilimab achieved full donor engraftment and full blood count [...]
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
15/03/2024
Nebula Genomics secures major international B2B deal – Additional significant B2B deals in final stages Ahead of schedule, Pharmaloz Manufacturing accelerates capacity expansion – set for rapid revenue and profit growth [...]
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®
15/03/2024
Proprietary catalytic gold nanocrystals comprising Clene’s investigational drug CNM-Au8 ® develop a protein corona upon exposure to human blood plasma comprised of proteins that promote blood-brain barrier penetration, [...]

Pages